CapsoVision (CV) Income from Continuing Operations (2024 - 2025)
CapsoVision recorded quarterly Income from Continuing Operations of 7394000.0 in Q4 2025, up 6.65% quarter-over-quarter from 7921000.0 in Q3 2025, and down 59.39% year-over-year from 18206351.38 in Q4 2024.
CapsoVision's Income from Continuing Operations history runs 2 years deep, the most recent figure standing at 7394000.0 for Q4 2025.
- In Q4 2025, Income from Continuing Operations fell 59.39% year-over-year to 7394000.0; the TTM figure through Dec 2025 stood at 24579000.0 (changed N/A YoY), while the FY2025 annual figure was 25315000.0, down 27.22% from the prior year.
- Income from Continuing Operations came in at 7394000.0 for Q4 2025 at CapsoVision, up from 7921000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 4625000.0 in Q2 2025 to a low of 7921000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 220.30 Mn |
| 10 | CapsoVision | 167.59 Mn | 157.48 Mn | 1.95 Mn | -7.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.39 Mn |
| Sep 30, 2025 | -7.92 Mn |
| Jun 30, 2025 | -4.63 Mn |
| Dec 31, 2024 | -4.64 Mn |
| Sep 30, 2024 | -5.79 Mn |
| Jun 30, 2024 | -5.27 Mn |